Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ishare Nasdaq Biotech ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 8,994,060,800
  • Shares Outstanding, K 29,000

Price Performance

See More
Period Period Low Period High Performance
1-Month
304.04 +1.86%
on 08/11/17
329.90 -6.13%
on 07/25/17
-5.39 (-1.71%)
since 07/17/17
3-Month
282.60 +9.59%
on 05/31/17
329.90 -6.13%
on 07/25/17
+21.10 (+7.31%)
since 05/17/17
52-Week
246.71 +25.53%
on 11/03/16
329.90 -6.13%
on 07/25/17
+18.79 (+6.46%)
since 08/17/16

Most Recent Stories

More News
3 ETFs to Watch Out for on Biotech Earnings

Major players in the biotech space reported their second quarter 2017 results.

IBB : 308.92 (-0.37%)
BBH : 126.34 (-0.55%)
BIB : 52.90 (-0.41%)
GILD : 72.52 (-1.13%)
AMGN : 169.41 (-1.16%)
ALXN : 136.46 (-0.07%)
BIIB : 289.49 (-1.56%)
3 ETFs to Watch Out for on Biotech Earnings

Major players in the biotech space reported their second quarter 2017 results.

IBB : 308.92 (-0.37%)
BBH : 126.34 (-0.55%)
BIB : 52.90 (-0.41%)
GILD : 72.52 (-1.13%)
AMGN : 169.41 (-1.16%)
ALXN : 136.46 (-0.07%)
BIIB : 289.49 (-1.56%)
Estimize Roundtable: What these experts say would have been a better path to Health Care reform

This week on the Estimize Roundtable, Estimize’s CEO, Leigh Drogen, and SVP of Media, Christine Short, are joined by Joe McCann, CEO and founder of Slingshot Insights, and and Spencer Jakab, Deputy Editor...

PETS : 46.25 (-0.49%)
VRTX : 150.49 (-0.58%)
IBB : 308.92 (-0.37%)
GILD : 72.52 (-1.13%)
BIIB : 289.49 (-1.56%)
This Scorching Trade Just Rocketed to the Top of Our List

This post This Scorching Trade Just Rocketed to the Top of Our List appeared first on Daily Reckoning . While 2017’s hottest stocks cooled off, a hidden breakout began to reveal itself. Today, Greg...

CELG : 129.46 (-1.37%)
XLV : 79.06 (-0.37%)
IBB : 308.92 (-0.37%)
XBI : 76.37 (-0.16%)
Biotech ETF Industry Outlook for Second Half 2017

There are several reasons to be positive on biotech stocks and ETFs for the rest of the year.

IBB : 308.92 (-0.37%)
XBI : 76.37 (-0.16%)
Can Biotech ETFs Continue to Surge Higher?

There are several reasons to be positive on biotech stocks and ETFs for the rest of the year.

IBB : 308.92 (-0.37%)
XBI : 76.37 (-0.16%)
Biotech ETF Industry Outlook for Second Half 2017

There are several reasons to be positive on biotech stocks and ETFs for the rest of the year.

IBB : 308.92 (-0.37%)
XBI : 76.37 (-0.16%)
Just the Facts, Ma'am: July Strategy Update

Just the Facts, Ma'am: July Strategy Update

ALL : 94.28 (-0.11%)
TOELY : 33.9900 (-0.29%)
DECK : 64.36 (-0.68%)
IBB : 308.92 (-0.37%)
Forget Big Tech, Biotech ETFs are Soaring Higher

Biotech stocks are surging of late; we discuss the reasons behind the rebound and highlight the best performing ETFs.

BBP : 38.44 (-0.06%)
BBC : 24.26 (-0.33%)
ARKG : 22.42 (-0.35%)
XLK : 57.83 (-0.76%)
IBB : 308.92 (-0.37%)
FBT : 114.10 (unch)
SPY : 245.88 (-0.43%)
XBI : 76.37 (-0.16%)
How Kite Pharma Is Revolutionizing the Fight Against Cancer

Immunotherapy is a hot corner of the biotech world. Learn how companies in this sector fight cancer in this podcast which features Dr. David Chang, the Chief Medical Officer of Kite Pharma. Do not miss...

CNCR : 22.47 (-0.09%)
IBB : 308.92 (-0.37%)
KITE : 128.53 (+0.34%)
XBI : 76.37 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Support & Resistance

2nd Resistance Point 313.57
1st Resistance Point 311.83
Last Price 308.92
1st Support Level 308.75
2nd Support Level 307.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.